CVE:KHRN Khiron Life Sciences (KHRN) Stock Price, News & Analysis → Will this AI Micro-Cap be Bigger than NVIDIA? (From Behind the Markets) (Ad) Free KHRN Stock Alerts C$0.04 0.00 (0.00%) (As of 05/5/2023) Add Compare Share Share Today's RangeC$0.04▼C$0.0550-Day RangeC$0.04▼C$0.0452-Week RangeC$0.04▼C$0.21Volume24,000 shsAverage Volume256,268 shsMarket CapitalizationC$9.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Khiron Life Sciences alerts: Email Address Ad Behind the MarketsBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.Get the full story here >>> About Khiron Life Sciences Stock (CVE:KHRN)Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.Read More KHRN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KHRN Stock News HeadlinesMay 23, 2024 | benzinga.comPharmadrug Stock (OTC:LMLLF), Quotes and News SummaryDecember 21, 2023 | msn.comFocus: Colombia's cannabis industry in crisis over regulatory, political hurdlesNovember 17, 2023 | benzinga.comGlobal Cannabis Co. Trading Lower On Announcing Amended European Business Sale DealNovember 16, 2023 | finance.yahoo.comKhiron Life Sciences Announces Update to the Proposed Sale of Its European BusinessMay 24, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT up on Friday (KHRN-WT)May 20, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Monday (KHRN)May 4, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT down on Tuesday (KHRN-WT)April 26, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Tuesday (KHRN)April 25, 2023 | msn.comCannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & MoreApril 25, 2023 | finance.yahoo.comMedical First: Germany Strengthens Reimbursement of Medical CannabisApril 22, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Friday (KHRN-WT)April 21, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp up on Thursday (KHRN)April 21, 2023 | msn.comKhiron Completes First Phase Of Business Optimization, Reduces Total Direct Labor Headcount By More Than 70% In Its Colombia SAS SubsidiaryApril 20, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Tuesday (KHRN-WT)April 15, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp flat on Friday (KHRN)April 14, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Wednesday (KHRN)April 14, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Thursday (KHRN-WT)April 7, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT flat on Wednesday (KHRN-WT)April 4, 2023 | finance.yahoo.comKhiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment OptionMarch 27, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES SIZING OF MARKETED OFFERING OF UNITSMarch 13, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT MARKETED OFFERINGFebruary 11, 2023 | theglobeandmail.comKhiron Life Sciences: Stocks Overvalued by Analyst Consensus on TSX-V (KHRN)January 19, 2023 | ca.finance.yahoo.comKhiron begins dispensation of insurance-covered prescriptions in ColombiaJanuary 19, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron begins dispensation of insurance-covered prescriptions in ColombiaJanuary 16, 2023 | benzinga.comNHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patientSee More Headlines Receive KHRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:KHRN CUSIPN/A CIKN/A Webwww.khiron.ca Phone705-527-3564FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-30,660,000.00 Net Margins-190.00% Pretax MarginN/A Return on Equity-74.68% Return on Assets-20.79% Debt Debt-to-Equity Ratio9.46 Current Ratio2.02 Quick Ratio0.72 Sales & Book Value Annual SalesC$16.14 million Price / Sales0.58 Cash FlowC$0.01 per share Price / Cash Flow6.67 Book ValueC$0.12 per share Price / Book0.33Miscellaneous Outstanding Shares232,410,000Free FloatN/AMarket CapC$9.30 million OptionableNot Optionable Beta2.64 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Alvaro Francisco Torres (Age 45)Co-Founder, CEO & Director Comp: $272.95kMs. Franziska KatterbachPresident of Khiron EuropeMr. Swapan Kakumanu ACA (Age 54)ACWA, CGA, Corporate Secretary Comp: $60kMr. Michael John O'Connor MA (Age 57)Chief Financial Officer Mr. Manuel BuendiaVice President of OperationsMr. Marco AlgortaCountry Manager of UruguayMore ExecutivesKey CompetitorsZomedica Pharmaceuticals Corp. (ZOM.V)CVE:ZOMCharlotte's WebTSE:CWEBInMed PharmaceuticalsTSE:INMeta GrowthCVE:METAMediPharm LabsTSE:LABSView All Competitors KHRN Stock Analysis - Frequently Asked Questions How have KHRN shares performed in 2024? Khiron Life Sciences' stock was trading at C$0.04 at the beginning of the year. Since then, KHRN shares have increased by 0.0% and is now trading at C$0.04. View the best growth stocks for 2024 here. What other stocks do shareholders of Khiron Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Khiron Life Sciences investors own include Aurora Cannabis (ACB), Cross Timbers Royalty Trust (CRT), Curaleaf (CURLF), Walt Disney (DIS), Energy Transfer (ET), KushCo (KSHB), Neptune Wellness Solutions (NEPT), Organigram (OGI) and VIVO Cannabis (VVCIF). How do I buy shares of Khiron Life Sciences? Shares of KHRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:KHRN) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Khiron Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Khiron Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.